SlideShare a Scribd company logo
1 of 10
Download to read offline
Secretion and Regulation of ApoB48 by
Primary Hamster Intestinal EnterocytesIntestinal Enterocytes
B C
LabeledApoB48(%control)
LabeledApoB48(%control)
0
20
40
60
80
100
120
Total Cells Media
Control
MG132
P < 0.05
0
20
40
60
80
100
120
Total Cells Media
Control
Oleate
P = 0.01
Cells Media
0 45 90 45 90
A
Chase Time (min)
Cells Media
Fructose-Fed
Chow-Fed
Chase Time (Min)
0 45 90 45 90
D
Chase Time (Min) Chase Time (Min)
100
100
0
10
20
30
40
50
60
70
80
90
0 20 40 60 80
Total apoB 48
LabeledApoB48(%of0Time)
LabeledApoB48(%of0Time)
p= 0.003 p= 0.001
Secreted apoB 48
0
10
20
30
40
50
60
70
80
90
100
0 20 40 60 80 100
Chow-Fed
Fructose-Fed
E F
Ex vivo evidence for oversecretion of intestinal apoB48
& Enhanced intracellular apoB48 stability in fructose-
fed hamster enterocytes
In Vivo Production of TG & Intestinal ApoB48
in the Fasting State
Time (min)
55 60 65 70 75 80 85
Sf>400TGconcentration
(mmol/l)
0
1
2
3
4
Sf >400 after Triton WR1339
Time (min)
55 60 65 70 75 80 85
Sf>400ApoB48concentration
(µg/ml)
140
160
180
200
220
240
260
280
Time (min)
55 60 65 70 75 80 85
Sf100-400TGconcentration
(mmol/l)
0
1
2
3
Sf 100-400 after Triton WR1339
Time (min)
55 60 65 70 75 80 85
Sf100-400ApoB48concentration
(µg/ml)
90
100
110
120
130
140
150
160
170
Triglyceridesecretion
0.0
0.2
0.4
0.6
0 1 2 3
ApoB48secretion
0
4
8
12
16
Triglyceridesecretion
0.0
0.1
0.2
0.3
ApoB48secretion
0
2
4
6p = 0.002 p = 0.01
p = 0.14
p = 0.59
A B
DC
In Vivo Production of TG & Intestinal ApoB48
in the Postprandial State
Time (min)
55 60 65 70 75 80 85
Triglyceridelevel(mmol/l)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
Time (min)
55 60 65 70 75 80 85
ApoB48level(µg/ml)
80
90
100
110
120
130
140
150
Time (min)
55 60 65 70 75 80 85
Triglyceridelevel(mmol/l)
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Time (min)
55 60 65 70 75 80 85
ApoB48level(µg/ml)
50
60
70
80
90
100
Triglyceridesecretion(µmol/min)
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
Col 48: 0.07
Col 48: 0.06
Triglyceridesecretion(µmol/min)
0.00
0.02
0.04
0.06
0.08
0.10
Col 50: 0.08
Col 50: 0.09
0 1 2 3
ApoB48secretion(µg/min)
0
1
2
3
4
5
6
7
8
Col 52: 2.65
Col 52: 7.46
ApoB48secretion(µg/min)
0
1
2
3
4
5
6
7
8
Col 54: 3.85
Col 54: 7.26
Sf 100-400 after Triton WR1339
Sf >400 after Triton WR1339
A B
C D
p = 0.3 p = 0.003
p = 0.8 p = 0.007
0
20
40
60
80
100
120
140
160
Fructose-Fed
MTPProteinMass
(%ofControl)
Chow-Fed Fructose-Fed
0
20
40
60
80
100
120
0 0.5 1 1.5 2 2.5 3 3.5
MTP inhibitor (µM)
ApoB48Secretion(%ofcontrol)
Fructose-fed
Chow-fed
∗
∗ ∗ ∗
Chow-Fed
p=0.006D
E
LabeledCholesterylEster
(%ofControl)
p= 0.002
0
50
100
150
200
250
Cellular
p=0.001
Media
B
LabeledCholesterol
(%ofControl)
Chow-Fed
Fructose-Fed
0
100
200
300
400
500
600
700
800
Cellular
p=0.0018
p=0.0013A
Media
LabeledTriglyceride
(%ofControl)
Cellular
0
20
40
60
80
100
120
140
160
180
p=0.04
p=0.003
Media
C
Ex Vivo Evidence for Intestinal Overproduction of
Lipoprotein Lipids and Increase MTP mass/activity
Fructose-Fed
Chow-fed
0
10
20
30
40
50
60
70
80
Large
CM
Small
CM
VLDL LDL HDL
p<0.05
p= 0.06
p<0.03
%ofTotalLabeledApoB48 A
0
20
40
60
80
100
120
140
CM apoB48 Total-apoB48
LabeledApoB48
(%ofFructose-fed)
p<0.0007
p<0.01C
0
10
20
30
40
50
60
70
80
Particles< 1.006 Particles > 1.006
%ofTotalLabeledAPoB48
p<0.024
p<0.026
B
0
40
20
60
80
100
120
CM apoB48 Total apoB48
LabeledApoB48
(%ofFructose-fed)
P=0.008 P=0.0001
DFasting Postprandial
Density/Size Distribution of Intestinal Lipoproteins
Evidence for Increased Number & Size
Increased De Novo Lipogenesis in FF Enterocytes
Evidence that ApoB48 Secretion is Linked to
the Rate of De Novo Lipogenesis
0
10
20
30
40
50
60
70
80
90
100
110
0 2 4 6 8 10 12 14 16
Cholesterol
Fatty Acid
Triglyceride
LabeledLipid(%ascontrol)
Cerulenin µg/ml
0
50
100
150
200
250
300
350
Chow-fed Fructose-fed
LabeledFattyAcid(%ascontrol)
0
10
20
30
40
50
60
70
80
90
100
110
0 2 4 6 8 10 12 14 16
Cerulenin µg/ml
LabeledSecretedApoB-48(%ascontrol)
A
C
p= 0.002
Sensitivity of ApoB48 Secretion
to Cerulenin
Fatty Acid
Synthesis
Sensitivity of TG & FA Secretion
to Cerulenin
20
60
80
100
0
40
120
Chow-fed Fructose-fed
(2 days)
0
20
40
60
80
100
120
Control Fructose
(3mM )
0
200
400
600
800
1000
enterocytes hepatocytes
P < 0.01
LabeledApoB-48(%ofcontrol)
LabeledApoB-48(%ofcontrol)
Labeledcholesterol
0
50
100
150
200
250
300
350
400
450
enterocytes hepatocytes
LabeledTriglyceride
P < 0.0001
Acute Fructose Feeding or Exposure Does NOT Affect
Intestinal ApoB48 Secretion
[14
C] Fructose
Incorporation
into TG &
Cholesterol
Two-day Fructose
Feeding In Vitro Incubation
of Enterocytes with
Fructose
Mechanisms of Intestinal Lipoprotein
Overproduction in Insulin Resistant/
Hyperinsulinemic States
Apical Surface
Basolateral Surface
FA
monoglyceride
FABP-FA
FABP
TG
TG
TG
ApoB48
PL
CE
De Novo (FA)
Insulin (??)
TGdietary
SOS
Grb-2
IRS
PI3-K
p110
SHP-2
NCK
PTKPTK
β β
α α
IR
PKB (Akt)
SREBP1c
FAS & ACC
Glucose
+
FA
MTP
ERER
GolgiGolgi
Intestinal
Enterocyte
TG
ApoB48 Lipoprotein
Particles
p85Proteasome
Degradation
Acknowledgements
Laboratory Group:
Changiz Taghibiglou
Mehran Haidari
Steven Van Iderstine
Wei Qui
Taryne Chong
Farhana Mahboob
Biao Chen
Leyla Mangaloglu
Louisa Pontrelli
Fariborz Rashid
Rita Kohen
Debbie Rudy
Collaborators:
Gary Lewis- Toronto
Andre Carpentier- Sherbrooke
Sven Olof Olofsson - Sweden
Janet Sparks - Rochester, NY
Raphael Cheung – Windsor
Michel Tremblay – Montreal
Denny Trinh - Toronto
Funding:
Heart & Stroke Foundation of Ontario
Canadian Institutes of Health Research
NSERC Hospital for Sick Children
Merck-Frosst pfizer
GlaxoSmithKline
BBDC, University of Toronto

More Related Content

Viewers also liked

176 coronary pan artritis
176 coronary pan artritis176 coronary pan artritis
176 coronary pan artritisSHAPE Society
 
038 tct arrow pics, landscape
038 tct arrow pics, landscape038 tct arrow pics, landscape
038 tct arrow pics, landscapeSHAPE Society
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)SHAPE Society
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factorSHAPE Society
 
220 statin therapy and coronary calcification
220 statin therapy and coronary calcification220 statin therapy and coronary calcification
220 statin therapy and coronary calcificationSHAPE Society
 
200 is coated stent the answer
200 is coated stent the answer200 is coated stent the answer
200 is coated stent the answerSHAPE Society
 
091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbits091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbitsSHAPE Society
 
502 nmr relaxation times
502 nmr relaxation times502 nmr relaxation times
502 nmr relaxation timesSHAPE Society
 
050 periadventitial fat
050 periadventitial fat050 periadventitial fat
050 periadventitial fatSHAPE Society
 
4th vulnerable plaque symposium
4th vulnerable plaque symposium4th vulnerable plaque symposium
4th vulnerable plaque symposiumSHAPE Society
 
058 optical coherence tomography
058 optical coherence tomography058 optical coherence tomography
058 optical coherence tomographySHAPE Society
 
3rd vp symposium jang
3rd vp symposium jang3rd vp symposium jang
3rd vp symposium jangSHAPE Society
 
129 inflammation and culprit lesions
129 inflammation and culprit lesions129 inflammation and culprit lesions
129 inflammation and culprit lesionsSHAPE Society
 
140 mr imaging of fibrin
140 mr imaging of fibrin140 mr imaging of fibrin
140 mr imaging of fibrinSHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)SHAPE Society
 
071 carotid array coil
071 carotid array coil071 carotid array coil
071 carotid array coilSHAPE Society
 
154 plaque rupture definition
154 plaque rupture definition154 plaque rupture definition
154 plaque rupture definitionSHAPE Society
 

Viewers also liked (20)

148 the erythrocyte
148 the erythrocyte148 the erythrocyte
148 the erythrocyte
 
176 coronary pan artritis
176 coronary pan artritis176 coronary pan artritis
176 coronary pan artritis
 
038 tct arrow pics, landscape
038 tct arrow pics, landscape038 tct arrow pics, landscape
038 tct arrow pics, landscape
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
 
220 statin therapy and coronary calcification
220 statin therapy and coronary calcification220 statin therapy and coronary calcification
220 statin therapy and coronary calcification
 
200 is coated stent the answer
200 is coated stent the answer200 is coated stent the answer
200 is coated stent the answer
 
091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbits091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbits
 
502 nmr relaxation times
502 nmr relaxation times502 nmr relaxation times
502 nmr relaxation times
 
050 periadventitial fat
050 periadventitial fat050 periadventitial fat
050 periadventitial fat
 
4th vulnerable plaque symposium
4th vulnerable plaque symposium4th vulnerable plaque symposium
4th vulnerable plaque symposium
 
058 optical coherence tomography
058 optical coherence tomography058 optical coherence tomography
058 optical coherence tomography
 
3rd vp symposium jang
3rd vp symposium jang3rd vp symposium jang
3rd vp symposium jang
 
129 inflammation and culprit lesions
129 inflammation and culprit lesions129 inflammation and culprit lesions
129 inflammation and culprit lesions
 
140 mr imaging of fibrin
140 mr imaging of fibrin140 mr imaging of fibrin
140 mr imaging of fibrin
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
071 carotid array coil
071 carotid array coil071 carotid array coil
071 carotid array coil
 
254 nanotechnology
254 nanotechnology254 nanotechnology
254 nanotechnology
 
165 pressure wire
165 pressure wire165 pressure wire
165 pressure wire
 
154 plaque rupture definition
154 plaque rupture definition154 plaque rupture definition
154 plaque rupture definition
 

More from SHAPE Society

More from SHAPE Society (20)

Barth imt
Barth imtBarth imt
Barth imt
 
Braunwald
BraunwaldBraunwald
Braunwald
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
103100
103100103100
103100
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02
 

Recently uploaded

DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Forensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationForensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationKavitha Krishnan
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)MedicoseAcademics
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint HealthArthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint HealthGokuldas Hospital
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 

Recently uploaded (20)

DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Forensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationForensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentation
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint HealthArthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
Arthroscopic Surgery in Indore : A Minimally Invasive Guide to Joint Health
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 

193 apo b48 secretion and regulation

  • 1. Secretion and Regulation of ApoB48 by Primary Hamster Intestinal EnterocytesIntestinal Enterocytes B C LabeledApoB48(%control) LabeledApoB48(%control) 0 20 40 60 80 100 120 Total Cells Media Control MG132 P < 0.05 0 20 40 60 80 100 120 Total Cells Media Control Oleate P = 0.01 Cells Media 0 45 90 45 90 A Chase Time (min)
  • 2. Cells Media Fructose-Fed Chow-Fed Chase Time (Min) 0 45 90 45 90 D Chase Time (Min) Chase Time (Min) 100 100 0 10 20 30 40 50 60 70 80 90 0 20 40 60 80 Total apoB 48 LabeledApoB48(%of0Time) LabeledApoB48(%of0Time) p= 0.003 p= 0.001 Secreted apoB 48 0 10 20 30 40 50 60 70 80 90 100 0 20 40 60 80 100 Chow-Fed Fructose-Fed E F Ex vivo evidence for oversecretion of intestinal apoB48 & Enhanced intracellular apoB48 stability in fructose- fed hamster enterocytes
  • 3. In Vivo Production of TG & Intestinal ApoB48 in the Fasting State Time (min) 55 60 65 70 75 80 85 Sf>400TGconcentration (mmol/l) 0 1 2 3 4 Sf >400 after Triton WR1339 Time (min) 55 60 65 70 75 80 85 Sf>400ApoB48concentration (µg/ml) 140 160 180 200 220 240 260 280 Time (min) 55 60 65 70 75 80 85 Sf100-400TGconcentration (mmol/l) 0 1 2 3 Sf 100-400 after Triton WR1339 Time (min) 55 60 65 70 75 80 85 Sf100-400ApoB48concentration (µg/ml) 90 100 110 120 130 140 150 160 170 Triglyceridesecretion 0.0 0.2 0.4 0.6 0 1 2 3 ApoB48secretion 0 4 8 12 16 Triglyceridesecretion 0.0 0.1 0.2 0.3 ApoB48secretion 0 2 4 6p = 0.002 p = 0.01 p = 0.14 p = 0.59 A B DC
  • 4. In Vivo Production of TG & Intestinal ApoB48 in the Postprandial State Time (min) 55 60 65 70 75 80 85 Triglyceridelevel(mmol/l) 0.0 0.1 0.2 0.3 0.4 0.5 0.6 Time (min) 55 60 65 70 75 80 85 ApoB48level(µg/ml) 80 90 100 110 120 130 140 150 Time (min) 55 60 65 70 75 80 85 Triglyceridelevel(mmol/l) 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 Time (min) 55 60 65 70 75 80 85 ApoB48level(µg/ml) 50 60 70 80 90 100 Triglyceridesecretion(µmol/min) 0.00 0.01 0.02 0.03 0.04 0.05 0.06 0.07 Col 48: 0.07 Col 48: 0.06 Triglyceridesecretion(µmol/min) 0.00 0.02 0.04 0.06 0.08 0.10 Col 50: 0.08 Col 50: 0.09 0 1 2 3 ApoB48secretion(µg/min) 0 1 2 3 4 5 6 7 8 Col 52: 2.65 Col 52: 7.46 ApoB48secretion(µg/min) 0 1 2 3 4 5 6 7 8 Col 54: 3.85 Col 54: 7.26 Sf 100-400 after Triton WR1339 Sf >400 after Triton WR1339 A B C D p = 0.3 p = 0.003 p = 0.8 p = 0.007
  • 5. 0 20 40 60 80 100 120 140 160 Fructose-Fed MTPProteinMass (%ofControl) Chow-Fed Fructose-Fed 0 20 40 60 80 100 120 0 0.5 1 1.5 2 2.5 3 3.5 MTP inhibitor (µM) ApoB48Secretion(%ofcontrol) Fructose-fed Chow-fed ∗ ∗ ∗ ∗ Chow-Fed p=0.006D E LabeledCholesterylEster (%ofControl) p= 0.002 0 50 100 150 200 250 Cellular p=0.001 Media B LabeledCholesterol (%ofControl) Chow-Fed Fructose-Fed 0 100 200 300 400 500 600 700 800 Cellular p=0.0018 p=0.0013A Media LabeledTriglyceride (%ofControl) Cellular 0 20 40 60 80 100 120 140 160 180 p=0.04 p=0.003 Media C Ex Vivo Evidence for Intestinal Overproduction of Lipoprotein Lipids and Increase MTP mass/activity
  • 6. Fructose-Fed Chow-fed 0 10 20 30 40 50 60 70 80 Large CM Small CM VLDL LDL HDL p<0.05 p= 0.06 p<0.03 %ofTotalLabeledApoB48 A 0 20 40 60 80 100 120 140 CM apoB48 Total-apoB48 LabeledApoB48 (%ofFructose-fed) p<0.0007 p<0.01C 0 10 20 30 40 50 60 70 80 Particles< 1.006 Particles > 1.006 %ofTotalLabeledAPoB48 p<0.024 p<0.026 B 0 40 20 60 80 100 120 CM apoB48 Total apoB48 LabeledApoB48 (%ofFructose-fed) P=0.008 P=0.0001 DFasting Postprandial Density/Size Distribution of Intestinal Lipoproteins Evidence for Increased Number & Size
  • 7. Increased De Novo Lipogenesis in FF Enterocytes Evidence that ApoB48 Secretion is Linked to the Rate of De Novo Lipogenesis 0 10 20 30 40 50 60 70 80 90 100 110 0 2 4 6 8 10 12 14 16 Cholesterol Fatty Acid Triglyceride LabeledLipid(%ascontrol) Cerulenin µg/ml 0 50 100 150 200 250 300 350 Chow-fed Fructose-fed LabeledFattyAcid(%ascontrol) 0 10 20 30 40 50 60 70 80 90 100 110 0 2 4 6 8 10 12 14 16 Cerulenin µg/ml LabeledSecretedApoB-48(%ascontrol) A C p= 0.002 Sensitivity of ApoB48 Secretion to Cerulenin Fatty Acid Synthesis Sensitivity of TG & FA Secretion to Cerulenin
  • 8. 20 60 80 100 0 40 120 Chow-fed Fructose-fed (2 days) 0 20 40 60 80 100 120 Control Fructose (3mM ) 0 200 400 600 800 1000 enterocytes hepatocytes P < 0.01 LabeledApoB-48(%ofcontrol) LabeledApoB-48(%ofcontrol) Labeledcholesterol 0 50 100 150 200 250 300 350 400 450 enterocytes hepatocytes LabeledTriglyceride P < 0.0001 Acute Fructose Feeding or Exposure Does NOT Affect Intestinal ApoB48 Secretion [14 C] Fructose Incorporation into TG & Cholesterol Two-day Fructose Feeding In Vitro Incubation of Enterocytes with Fructose
  • 9. Mechanisms of Intestinal Lipoprotein Overproduction in Insulin Resistant/ Hyperinsulinemic States Apical Surface Basolateral Surface FA monoglyceride FABP-FA FABP TG TG TG ApoB48 PL CE De Novo (FA) Insulin (??) TGdietary SOS Grb-2 IRS PI3-K p110 SHP-2 NCK PTKPTK β β α α IR PKB (Akt) SREBP1c FAS & ACC Glucose + FA MTP ERER GolgiGolgi Intestinal Enterocyte TG ApoB48 Lipoprotein Particles p85Proteasome Degradation
  • 10. Acknowledgements Laboratory Group: Changiz Taghibiglou Mehran Haidari Steven Van Iderstine Wei Qui Taryne Chong Farhana Mahboob Biao Chen Leyla Mangaloglu Louisa Pontrelli Fariborz Rashid Rita Kohen Debbie Rudy Collaborators: Gary Lewis- Toronto Andre Carpentier- Sherbrooke Sven Olof Olofsson - Sweden Janet Sparks - Rochester, NY Raphael Cheung – Windsor Michel Tremblay – Montreal Denny Trinh - Toronto Funding: Heart & Stroke Foundation of Ontario Canadian Institutes of Health Research NSERC Hospital for Sick Children Merck-Frosst pfizer GlaxoSmithKline BBDC, University of Toronto